Pharmacovigilance Market Size, Share & Trends Analysis Report By Clinical Trial Phase (Pre-Clinical, Phase I, II, III, IV), By Service Provider (In-House, Contract Outsourcing), By Type, By End Use, And Segment Forecasts, 2020 - 2027

Table of Contents

Chapter 1 Research Methodology & Scope

1.1 Market Segmentation & Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Report Objectives

Chapter 2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Pharmacovigilance Market Summary, 2019

Chapter 3 Pharmacovigilance Market Variables, Trends & Scope

3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.3 Ancillary market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Market influencer analysis
3.4 List of Key End Users
3.5 Regulatory Framework
3.5.1 Regulatory Landscape
3.6 Technology Overview
3.6.1 Pharmacovigilance timeline analysis
3.7 Pharmacovigilance Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Growing drug consumption and drug development rates
3.7.1.2 Increasing incidence of ADR and drug toxicity
3.7.1.3 Rising trend of outsourcing pharmacovigilance services
3.7.1.4 Accelearting demand for personalised medicines
3.7.2 Market restraint analysis
3.7.2.1 Lack of skilled labor
3.7.2.2 High risk associated with data security
3.8 Industry Analysis - Porter’s
3.9 Pharmacovigilance - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.10 Major Deals & Strategic Alliances Analysis
3.10.1 Mergers & Acquisitions
3.10.2 Product launch
3.10.3 Expansion
3.10.4 Partnership & Collaborations
3.10.5 Market Entry Strategies

Chapter 4 Pharmacovigilance Market: Competitive Analysis

4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Market leader
4.2.3 Innovators
4.2.4 Vendor Landscape
4.2.4.1 List of pharmacovigilance service providers
4.2.5 Company Market Share
4.2.6 Competitive Dashboard Analysis

Chapter 5 Pharmacovigilance Market: Process Flow Insights

5.1 Case data management
5.1.1 Case logging
5.1.2 Case data analytics
5.1.3 Medical reviewing and reporting
5.2 Signal detection
5.2.1 Adverse event logging
5.2.2 Adverse event analysis
5.2.3 Adverse event review & reporting
5.3 Risk management system
5.3.1 Risk evaluation
5.3.2 Risk mitigation system

Chapter 6 Pharmacovigilance Market: Product Estimates & Trend Analysis

 6.1 Product Market Share Analysis, 2019 & 2027
6.2 Product Dashboard
6.2.1 Preclinical
6.2.1.1 Preclinical market estimates and forecasts, 2016 - 2027 (USD Million)
6.2.2 Phase I
6.2.2.1 Phase I market estimates and forecasts, 2016 - 2027 (USD Million)
6.2.3 Phase II
6.2.3.1 Phase II market estimates and forecasts, 2016 - 2027 (USD Million)
6.2.4 Phase III
6.2.4.1 Phase III market estimates and forecasts, 2016 - 2027(USD Million)
6.2.5 Phase IV
6.2.5.1 Phase IV market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 7 Pharmacovigilance Market: Service provider Estimates & Trend Analysis

7.1 Service provider Market Share Analysis, 2019 & 2027
7.2 Service Provider Dashboard
7.3 In house
7.3.1 In house market estimates and forecasts, 2016 - 2027 (USD Million)
7.4 Contract outsourcing
7.4.1 Contract outsourcing market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 8 Pharmacovigilance Market: Type Estimates & Trend Analysis

8.1 Type Market Share Analysis, 2019 & 2027
8.2 Type Dashboard
8.3 Spontaneous Reporting
8.3.1 Spontaneous Reporting market estimates and forecasts, 2016 - 2027 (USD Million)
8.4 Intensified ADR Reporting
8.4.1 Intensified ADR Reporting market estimates and forecasts, 2016 - 2027 (USD Million)
8.5 Targeted spontaneous reporting
8.5.1 Targeted spontaneous reporting market estimates and forecasts, 2016 - 2027 (USD Million)
8.6 Cohort Event Monitoring (CEM)
8.6.1 Cohort Event Monitoring (CEM) market estimates and forecasts, 2016 - 2027 (USD Million)
8.7 EHR Mining
8.7.1 EHR Mining market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 9 Pharmacovigilance Market: End-Use Estimates & Trend Analysis

9.1 End-Use Market Share Analysis, 2019 & 2027
9.2 End-Use Dashboard
9.3 Hospitals
9.3.1 Hospitals market estimates and forecasts, 2016 - 2027 (USD Million)
9.4 Research organizations
9.4.1 Research organizations market estimates and forecasts, 2016 - 2027 (USD Million)
9.5 Industrial
9.5.1 Industrial market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 10 Pharmacovigilance Market: Regional Estimates & Trend Analysis, By, Product, Service Providers, Type, And End-Use

10.1 Regional Market Share Analysis, 2019 & 2027
10.2 Regional Market Dashboard
10.3 Regional Market Snapshot
10.4 Market Share Analysis by Country, 2019
10.4.1 North America
10.4.2 Europe
10.4.3 Asia Pacific
10.4.4 Latin America
10.4.5 MEA
10.5 North America
10.5.1 North America Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.5.2 U.S.
10.5.2.1 U.S. Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.5.3 Canada
10.5.3.1 Canada Pharmacovigilance market estimates and forecasts, 2016 - 2027(USD Million)
10.6 Europe
10.6.1 Europe Pharmacovigilance MARKET estimates and forecasts, 2016 - 2027 (USD Million)
10.6.2 U.K.
10.6.2.1 U.K. Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.3 Germany
10.6.3.1 Germany Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.4 France
10.6.4.1 France Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.5 Italy
10.6.5.1 Italy Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.6 Spain
10.6.6.1 Spain Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.7 Russia
10.6.7.1 Russia Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.7 Asia Pacific
10.7.1 Asia Pacific Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.7.2 Japan
10.7.2.1 Japan Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.7.3 China
10.7.3.1 China Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.7.4 India
10.7.4.1 India Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.8 Latin America
10.8.1 Latin America Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.8.2 Mexico
10.8.2.1 Mexico Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.8.3 Brazil
10.8.3.1 Brazil Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.9 MEA
10.9.1 MEA Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.9.2 South Africa
10.9.2.1 South Africa Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)
10.9.3 Saudi Arabia
10.9.3.1 Saudi Arabia Pharmacovigilance market estimates and forecasts, 2016 - 2027 (USD Million)

Chapter 11 Company Profiles

11.1 Accenture
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Strategic initiatives
11.2 Linical Accelovance
11.2.1 Company overview
11.2.2 Product benchmarking
11.2.3 Strategic initiatives
11.3 Cognizant
11.3.1 Company overview
11.3.2 Financial Performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Laboratory Corporation of America Holdings
11.4.1 Company overview
11.4.2 Financial Performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 IBM Corporation
11.5.1 Company overview
11.5.2 Financial Performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 ArisGlobal
11.6.1 Company overview
11.6.2 Financial Performance
11.6.3 Product benchmarking
11.6.4 Strategic initiatives
11.7 ICON Plc
11.7.1 Company overview
11.7.2 Product benchmarking
11.8 Capgemini
11.8.1 Company overview
11.8.2 Financial Performance
11.8.3 Product benchmarking
11.8.4 Strategic initiatives
11.9 FMD K&L
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
11.10 IT Clinical
11.10.1 Company overview
11.10.2 Financial performance
11.10.3 Product benchmarking
11.10.4 Strategic initiatives
11.11 IQVIA
11.11.1 Company overview
11.11.2 Financial performance
11.11.3 Product benchmarking
11.11.4 Strategic initiatives
11.12 TAKE Solutions
11.12.1 Company overview
11.12.2 Financial performance
11.12.3 Product benchmarking
11.12.4 Strategic initiatives
11.13 PAREXEL International Corporation
11.13.1 Company overview
11.13.2 Financial performance
11.13.3 Product benchmarking
11.13.4 Strategic initiatives
11.14 BioClinica, Inc.
11.14.1 Company overview
11.14.2 Financial performance
11.14.3 Product benchmarking
11.14.4 Strategic initiatives
11.15 Wipro Limited
11.15.1 Company overview
11.15.2 Financial performance
11.15.3 Product benchmarking
11.15.4 Strategic initiatives
11.16 United BioSource Corporation
11.16.1 Company overview
11.16.2 Financial performance
11.16.3 Product benchmarking
11.16.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 List of pharmacovigilance service providers
Table 4 North America pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 5 North America pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 6 North America pharmacovigilance market, by type , 2016 - 2027 (USD Million)
Table 7 North America pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 8 U.S. pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 9 U.S. pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 10 U.S. pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 11 U.S. pharmacovigilance market, by end use, 2016 - 2027 (USD Million)
Table 12 Canada pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 13 Canada pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 14 Canada pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 15 Canada pharmacovigilance market, by end use, 2016 - 2027 (USD Million)
Table 16 Europe pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 17 Europe pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 18 Europe pharmacovigilance market, by type , 2016 - 2027 (USD Million)
Table 19 Europe pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 20 U.K. pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 21 U.K. pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 22 U.K. pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 23 U.K. pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 24 Germany pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 25 Germany pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 26 Germany pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 27 Germany pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 28 France pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 29 France pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 30 France pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 31 France pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 32 Italy pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 33 Italy pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 34 Italy pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 35 Italy pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 32 Spain pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 33 Spain pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 34Spain pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 35Spain pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 36 Russia pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 37 Russia pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 38 Russia pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 39 Russia pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 40 Asia Pacific pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 41 Asia Pacific pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 42 Asia Pacific pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 43 Asia Pacific pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 44 Japan pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 45 Japan pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 46 Japan pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 47 Japan pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 48 China pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 49 China pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 50 China pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 51 China pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 52 India pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 53 India pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 54 India pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 55 India pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 56 Latin America pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 57 Latin America pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 58 Latin America pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 59 Latin America pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 60 Mexico pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 61 Mexico pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 62 Mexico pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 63 Mexico pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 64 Brazil pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 65 Brazil pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 66 Brazil pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 67 Brazil pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 68 MEA pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 69 MEA pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 70 MEA pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 71 MEA pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 72 South Africa pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 73 South Africa pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 74 South Africa pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 75 South Africa pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)
Table 76 Saudi Arabia pharmacovigilance market, by clinical phase, 2016 - 2027 (USD Million)
Table 77 Saudi Arabia pharmacovigilance market, by service provider, 2016 - 2027 (USD Million)
Table 78 Saudi Arabia pharmacovigilance market, by type, 2016 - 2027 (USD Million)
Table 79 Saudi Arabia pharmacovigilance market, by end-use, 2016 - 2027 (USD Million)

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Pharmacovigilance executive summary, 2019 (USD Millions)
Fig. 11 Pharmacovigilance market revenues, 2019 (USD Millions)
Fig. 12 Segment Outlook
Fig. 13 Strategy framework
Fig. 14 Pharmacovigilance market snapshot
Fig. 15 Parent market outlook
Fig. 16 Ancillary market outlook
Fig. 17 Penetration & growth prospect mapping
Fig. 18 Pharmacovigilance trend analysis
Fig. 19 Pharmacovigilance timeline analysis
Fig. 20 Pharmacovigilance market dynamics
Fig. 21 Pharmacovigilance market driver impact
Fig. 22 Pharmacovigilance market restraint impact
Fig. 23 Porter’s five force model
Fig. 24 Pharmacovigilance - SWOT analysis, by factor (political & legal, economic and technological)
Fig. 25 Strategy mapping
Fig. 26 Market participant categorization
Fig. 27 Company market position analysis
Fig. 28 Company market share analysis
Fig. 29 Competitive dashboard analysis
Fig. 30 Pharmacovigilance market: Product movement analysis
Fig. 31 Pharmacovigilance market product dashboard
Fig. 32 Global Preclinical market, 2016 - 2027 (USD Million)
Fig. 33 Global Phase I market, 2016 - 2027 (USD Million)
Fig. 34 Global Phase II market, 2016 - 2027 (USD Million)
Fig. 35 Global Phase III market, 2016 - 2027 (USD Million)
Fig. 36 Global Phase IV market, 2016 - 2027 (USD Million)
Fig. 37 Pharmacovigilance market: Service provider movement analysis
Fig. 38 Pharmacovigilance service provider dashboard
Fig. 39 Global In house market, 2016 - 2027 (USD Million)
Fig. 40 Global Contract outsourcing market, 2016 - 2027 (USD Million)
Fig. 41 Pharmacovigilance market: Type movement analysis
Fig. 42 Pharmacovigilance Type dashboard
Fig. 43 Global Spontaneous Reporting market, 2016 - 2027 (USD Million)
Fig. 44 Global Intensified ADR Reporting market, 2016 - 2027 (USD Million)
Fig. 45 Global Targeted spontaneous reporting market, 2016 - 2027 (USD Million)
Fig. 46 Global Cohort Event Monitoring (CEM) market, 2016 - 2027 (USD Million)
Fig. 47 Global EHR Mining market, 2016 - 2027 (USD Million)
Fig. 48 Pharmacovigilance market: End-use movement analysis
Fig. 49 Pharmacovigilance End-use dashboard
Fig. 50 Global Hospitals market, 2016 - 2027 (USD Million)
Fig. 51 Global Research organizations market, 2016 - 2027 (USD Million)
Fig. 52 Regional market place: Key takeaways
Fig. 53 North America Pharmacovigilance market share by countries, 2019
Fig. 54 Europe Pharmacovigilance market share by countries, 2019
Fig. 55 Asia Pacific pharmacovigilance market share by countries, 2019
Fig. 56 Latin America pharmacovigilance market share by countries, 2019
Fig. 57 MEA Pharmacovigilance market share by countries, 2019
Fig. 58 Regional outlook, 2019 & 2027
Fig. 59 North America Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 60 U.S. Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 61 Canada Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 62 Europe Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 63 U.K. Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 64 Germany Pharmacovigilance market, 2016 - 2027(USD Million)
Fig. 65 France Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 66 Italy pharmacovigilance market, 2016 - 2027(USD Million)
Fig. 67 Spain pharmacovigilance market, 2016 - 2027(USD Million)
Fig. 68 Russia Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 69 Asia Pacific Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 70 Japan Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 71 China Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 72 India Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 73 Latin America Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 74 Mexico Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 75 Brazil Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 76 MEA Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 77 South Africa Pharmacovigilance market, 2016 - 2027 (USD Million)
Fig. 78 Saudi Arabia Pharmacovigilance market, 2016 - 2027 (USD Million)

当レポートのプレスリリースは発行されておりません。